Table 1 Significantly enriched GO terms and KEGG pathways.

GO_BP

GO:0009954

proximal/distal pattern formation

1.1E-09

GO:0048665

neuron fate specification

2.8E-08

GO:0035115

embryonic forelimb morphogenesis

2.1E-07

GO:0009952

anterior/posterior pattern specification

5.9E-07

GO:0021522

spinal cord motor neuron differentiation

8.0E-05

GO:0072189

ureter development

8.2E-05

GO:0001764

neuron migration

9.8E-05

GO:0045944

positive regulation of transcription from RNA polymerase II promoter

1.3E-04

GO:0045666

positive regulation of neuron differentiation

6.7E-04

GO:0045665

negative regulation of neuron differentiation

1.1E-03

GO:0007267

cell-cell signaling

1.1E-03

GO:0035116

embryonic hindlimb morphogenesis

3.2E-03

GO:0001759

organ induction

5.3E-03

GO:0003148

outflow tract septum morphogenesis

9.6E-03

GO:0002053

positive regulation of mesenchymal cell proliferation

1.5E-02

GO:0007517

muscle organ development

2.2E-02

GO:0009948

anterior/posterior axis specification

2.9E-02

GO:0048557

embryonic digestive tract morphogenesis

3.2E-02

GO:0048664

neuron fate determination

3.2E-02

GO:0021527

spinal cord association neuron differentiation

3.2E-02

GO:0032332

positive regulation of chondrocyte differentiation

3.2E-02

GO:0048701

embryonic cranial skeleton morphogenesis

3.9E-02

GO_MF

GO:0043565

sequence-specific DNA binding

1.6E-10

GO:0001077

transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding

2.2E-10

GO:0000978

RNA polymerase II core promoter proximal region sequence-specific DNA binding

1.1E-06

GO:0003682

chromatin binding

1.3E-06

GO:0000977

RNA polymerase II regulatory region sequence-specific DNA binding

2.1E-02

GO_CC

GO:0005667

transcription factor complex

9.0E-06

GO:0005634

nucleus

6.6E-03

KEGG

5200

Pathways in cancer

3.2E-04

4080

Neuroactive ligand-receptor interaction

2.3E-03

4950

Maturity onset diabetes of the young

3.2E-03